Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K FOLKERS

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Clinical Physiology (Oxford, England)|August 1, 1988
Coenzyme Q10 content in different parts of the normal human heartL Lin, P Sotonyi, E Somogyi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1974
Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophyK Folkers, R Nakamura, G P Littarru, et al.
Journal of Cardiovascular Pharmacology|August 1, 1996
Hemostatic changes after dietary coenzyme Q10 supplementation in swineV L Serebruany, W R Herzog, S P Atamas, et al.
Molecular Aspects of Medicine|January 1, 1997
Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor?V L Serebruany, P A Gurbel, J V Ordoñez, et al.
Brain Research|November 5, 1990
Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicityM S Reid, T Hökfelt, M Herrera-Marschitz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1997
Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expressionV L Serebruany, J V Ordonez, W R Herzog, et al.
The American Journal of Clinical Nutrition|October 1, 1979
Clinical results of a cross-over treatment with pyridoxine and placebo of the carpal tunnel syndromeJ Ellis, K Folkers, T Watanabe, et al.
Biochemical and Biophysical Research Communications|September 28, 1984
Antagonists of the luteinizing hormone releasing hormone (LHRH) with emphasis on the TRP7 of the salmon and chicken II LHRH'sK Folkers, C Y Bowers, H M Shieh, et al.
European Journal of Pharmacology|August 1, 1994
Pharmacological assessment of spantide II analoguesZ Y Wang, D M Feng, Y L Wang, et al.
Oncogene|February 19, 2013
CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stromaA Shukla, R Edwards, Y Yang, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Clinical Physiology (Oxford, England)|August 1, 1988
Coenzyme Q10 content in different parts of the normal human heartL Lin, P Sotonyi, E Somogyi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1974
Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophyK Folkers, R Nakamura, G P Littarru, et al.
Journal of Cardiovascular Pharmacology|August 1, 1996
Hemostatic changes after dietary coenzyme Q10 supplementation in swineV L Serebruany, W R Herzog, S P Atamas, et al.
Molecular Aspects of Medicine|January 1, 1997
Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor?V L Serebruany, P A Gurbel, J V Ordoñez, et al.
Brain Research|November 5, 1990
Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicityM S Reid, T Hökfelt, M Herrera-Marschitz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1997
Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expressionV L Serebruany, J V Ordonez, W R Herzog, et al.
The American Journal of Clinical Nutrition|October 1, 1979
Clinical results of a cross-over treatment with pyridoxine and placebo of the carpal tunnel syndromeJ Ellis, K Folkers, T Watanabe, et al.
Biochemical and Biophysical Research Communications|September 28, 1984
Antagonists of the luteinizing hormone releasing hormone (LHRH) with emphasis on the TRP7 of the salmon and chicken II LHRH'sK Folkers, C Y Bowers, H M Shieh, et al.
European Journal of Pharmacology|August 1, 1994
Pharmacological assessment of spantide II analoguesZ Y Wang, D M Feng, Y L Wang, et al.
Oncogene|February 19, 2013
CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stromaA Shukla, R Edwards, Y Yang, et al.
Pageof 21